BRIC > Research
Research at BRIC
Disease-oriented basic research is the main focus of the research at BRIC. Our overall aim is to contribute to a basic understanding of how and why disease occurs, to discover new disease-related genes, and to identify new diagnostic markers, which are essential to provide more efficient treatment. From 2011, BRIC has entered into a scientific collaboration with the Finsen Laboratory, Rigshospitalet, to coordinate our cancer research projects. We currently have 19 research groups working on research projects relevant for cancer, neurological and metabolic diseases. Click on the group name below if you wish to know more about their research:
 |
Bioinformatics Group miRNA, ancient DNA, disease transcriptomics, gene regulation |
 |
Behrendt Group Cancer invasion, metastasis, degredation of extracellular matrix, collagen endocytosis |
|
 |
Brakebusch Group Rho GTPases, mouse models, cancer, inflammation |
 |
Couchman Group Cell adhesion, receptors, signaling, cytoskeleton, syndecan |
|
 |
Engelholm Group Cancer invasion, UPAR, MMPs, proteases, extracellular matrix degradtion |
 |
Erler Group Hypoxia and metastasis, lysyl oxidases, tissue stiffness, network medicine |
|
 |
Frödin Group Protein kinase signal transduction, cancer biology, epigenetics, metastasis models |
 |
Groth Group Chromatin replication, epigenetics, genome stability |
|
 |
Hansen Group Signaling to chromatin, epigenetics, stem cells, cancer |
 |
Helin Group Epigenetics, stem cells, cancer biology |
|
 |
Høyer-Hansen Group Experimental treatment, proteolysis, immuno-assays, biomakers, monoclonal antibodies |
 |
Issazadeh-Navikas Group Glioblastoma, neuroinflammation neurodegeneration, neuron-T cell signaling, neuroimmunology |
|
 |
Jensen Group Somatic stem cells, cancer stem cells |
 |
Lund Group Non-coding RNA, epigenetics, cancer models |
|
 |
Ploug Group Protein structure and function at cancer invasion, metastasis, extracellular matrix degradation |
 |
Pocock Group Neurobiology, microRNAs, stress |
|
 |
Porse Group Hematopoietic/cancer stem cells, leukemia, nonsense-mediated mRNA decay |
 |
Salcini Group C. elegans development, chromatin, histone methylation |
|
 |
Sørensen Group Genome maintenance, chromatin, DNA damage response |
 |
Wewer Group ADAM metalloproteases, integrins, cellular interactions and migration, signaling, cancer |
